Rankings
▼
Calendar
TVTX FY 2015 Earnings — Travere Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
TVTX
Travere Therapeutics, Inc.
$3B
FY 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$100M
+254.2% YoY
Gross Profit
$98M
97.8% margin
Operating Income
-$51M
-50.8% margin
Net Income
$117M
117.4% margin
EPS (Diluted)
$3.17
Cash Flow
Operating Cash Flow
-$554,000
Free Cash Flow
-$8M
Stock-Based Comp.
$26M
Balance Sheet
Total Assets
$512M
Total Liabilities
$212M
Stockholders' Equity
$300M
Cash & Equivalents
$38M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$100M
$28M
+254.2%
Gross Profit
$98M
$28M
+253.6%
Operating Income
-$51M
-$80M
+36.4%
Net Income
$117M
-$111M
+205.7%
← FY 2014
All Quarters
Q1 2016 →